Abstract:Agnieszka Tuzimek, 1 Ewelina A Dziedzic, 1 Joanna Beck, 2, 3 Wac&lstrokaw Kochman 1 1 Cardiovascular Clinic, Centre of Postgraduate Medical Education, Warsaw, 01-813, Poland; 2 Bioimaging Research Center, Institute of Physiology and Pathology of Hearing, Warsaw, 02-042, Poland; 3 Medical Faculty, Lazarski University, Warsaw, 02-662, Poland Correspondence: Ewelina A Dziedzic, Cardiovascular Clinic, Centre of Postgraduate Medical Education, 99/103 Marymoncka St, Warsaw, 01-813, Poland, Email Purpose: Type 2 diabetes mellitus (DM) is a recognized independent risk factor for both chronic coronary syndrome (CCS) and its complication, acute coronary syndrome (ACS). Patients with DM and prediabetes (preDM) face an increased ACS risk. Inflammation plays a significant role in the pathogenesis of both CCS and ACS. This study delves into novel inflammatory markers, such as the systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and aggregate index of systemic inflammation (AISI, also known as SIIRI or PIV), to explore their relationship with ACS and CCS in patients that have been or have not been diagnosed with DM or preDM. Patients and Methods: This study included data of 493 patients with chest pain undergoing coronary angiography. They were categorized into four groups: 1) without DM/preDM and with CCS; 2) with both DM/preDM and CCS; 3) without DM/preDM and with ACS, 4) with both DM/preDM and ACS. Standard methods of statistical analysis were used to reveal possible differences between groups and to find the most influential ACS risk factors in groups with DM/preDM and without DM/preDM. Results: The analysis showed no significant differences in SII, SIRI, or AISI between the respective patient groups. A logistic regression analysis generated a model incorporating SII, high-density lipoprotein, and low-density lipoprotein levels as the influential ACS risk factors for patients with DM/preDM. The model demonstrated 71.0% accuracy, 37.0% sensitivity, and 89.4% specificity. Conclusion: The findings suggest that the aforementioned inflammatory markers may have potential for distinguishing DM/preDM patients at higher risk of ACS at a low financial cost. However, further comprehensive and well-designed research is required to validate their clinical utility. Plain Language Summary: People with type 2 diabetes (DM) and prediabetes (preDM) have a higher risk of heart problems. These include chronic coronary syndrome (CCS) and acute coronary syndrome (ACS). Inflammation is a key element in these issues. We looked at 493 patients with chest pain. We divided them into groups based on diabetes status (DM/preDM vs no diabetes) and heart conditions (ACS and CCS). We explored new markers related to inflammation. These include the systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and aggregate index of systemic inflammation (AISI) that all can be calculated from simple blood tests. We found no differences in these markers between groups. To understand ACS risk factors better, we used statistical analysis. The model found key factors for patients with DM/preDM: SII, LDL, and low-density lipoprotein levels. It was accurate (71.0%), but sensitivity was 37.0%, and specificity was 89.4%. These markers could be helpful in identifying DM/preDM patients at risk of ACS with low cost tests. We need more research to confirm their use in real-life medical settings. Keywords: coronary artery disease, ischemic heart disease, atherosclerosis, myocardial infarction, pan-immune-inflammation value, systemic immune-inflammation response index, systemic immune-inflammation index, diabetes Type 2 diabetes mellitus (DM) is an independent risk factor for chronic coronary syndrome (CCS) and its complication, acute coronary syndrome (ACS). 1 Epidemiological data revealed that almost a third of DM patients are concurrently affected with cardiovascular disease, and approximately one in ten suffered from ACS. 2 Inflammation is a pivotal factor in the pathogenesis of both DM and atherosclerosis, one of the underlying causes of CCS. 3 Inflammatory processes influence various mechanisms involved in atherosclerotic plaque formation and rupture, ultimately culminating in the onset of ACS. 4 Recently, the degree of inflammation has been characterized in terms of the ratios of various leukocyte subtypes in the complete blood count: the systemic immune-inflammation index (SII) the systemic inflammation response index (SIRI), and the aggregate index of systemic inflammation (AISI), which is also referred to as systemic immune-inflammation response index (SIIRI) or -Abstract Truncated-

Inflammation and Insulin Resistance in Diabetic Chronic Coronary Syndrome Patients

Association Of Periodontal Parameters With Metabolic Level And Systemic Inflammatory Markers In Patients With Type 2 Diabetes

The combined effect of triglyceride-glucose index and high-sensitivity C-reactive protein on cardiovascular outcomes in patients with chronic coronary syndrome: A multicenter cohort study

Impact of Glycemic Control on Coronary Inflammation Evaluated by Computed Tomography Pericoronary Fat Attenuation Index in Patients with Acute Coronary Syndrome

Coronary inflammation based on pericoronary adipose tissue attenuation in type 2 diabetic mellitus: effect of diabetes management

The Combined Effect of Systemic Immune-Inflammation Index and Type 2 Diabetes Mellitus on the Prognosis of Patients Undergoing Percutaneous Coronary Intervention: A Large-Scale Cohort Study

Insulin resistance and coronary inflammation in patients with coronary artery disease: a cross-sectional study

Temporal relationship between inflammation and insulin resistance and their joint effect on hyperglycemia: the Bogalusa Heart Study

Analysis of Risk Factors of Coronary Heart Disease and Its Correlation with Inflammatory Factors in Patients with Type 2 Diabetes Mellitus

Correlations Between Acute Coronary Syndrome and Novel Inflammatory Markers (Systemic Immune-Inflammation Index, Systemic Inflammation Response Index, and Aggregate Index of Systemic Inflammation) in Patients with and without Diabetes or Prediabetes

Mediation of Systemic Inflammation on Insulin Resistance and Prognosis of Nondiabetic Patients With Ischemic Stroke

Associations of cardiometabolic index with diabetic statuses and insulin resistance: the mediating role of inflammation-related indicators

Evaluating the impact of chronic kidney disease and the triglyceride-glucose index on cardiovascular disease: mediation analysis in the NHANES

C-reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinediones

Association of triglyceride-glucose index with adverse cardiovascular events in patients with established coronary artery disease according to different inflammatory status

Impact of diabetes mellitus and triglyceride glucose index on mortality and cardiovascular outcomes in patients with chronic coronary syndrome undergoing coronary computed tomography angiography

Serum Interleukin-6 And Interferon-Gamma Are Associated With The Severity Of Coronary Disease In Patients With Acute Coronary Syndrome And Type-2 Diabetes

The relationship of serum inflammatory factors, adiponectin and early atherosclerotic in type 2 diabetes

Increased Peripheral Proinflammatory T Helper Subsets Contribute to Cardiovascular Complications in Diabetic Patients.

[Impact of Insulin Resistance on Prognosis in Non-Diabetic Patients with Acute Coronary Syndromes].

Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes